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Surgical Intervention for HIV Related Vascular Disease
Botes K., Van Marle J. Eur J Vasc Endovasc Surg 2007;34:390-96.
Objectives: To determine the outcome of surgical intervention in
patients with HIV associated vascular disease.
Design: Prospective clinical survey.
Materials and methods: Routine voluntary testing for HIV/AIDS
was performed in patients who presented to our unit with peripheral vascular
disease. One hundred and nine patients (5.7%) were prospectively identified
over a 5-year period (2001–2006).
Results: 24 patients presented with aneurysmal disease whilst occlusive
disease was present in 66 patients. There was not much difference between
patients with aneurysmal disease and patients with occlusive disease as to age,
CD4 count and other risk factors for vascular disease. The peri-operative
mortality for aneurysmal disease was 10.6% versus 3.6% for occlusive disease
(p0.264). Long-term mortality was significantly worse (p0.049) for
patients with aneurysmal disease. The results of revascularization in occlusive
disease were poor with a limb salvage rate of 31.6%. There was no significant
difference in CD4 T-cell counts between primary amputation and revascu-
larization groups (p0.058).
Conclusion: Patients with aneurysmal disease have a high peri-opera-
tive and long-term mortality and it appears that surgical intervention should
be reserved for life-threatening aneurysms only. Patients with occlusive
disease have a better survival rate but limb salvage is poor. Primary amputa-
tion may be preferable to bypass surgery in patients with critical limb
ischaemia.
Smoking Cessation Interventions in Clinical Practice
Cornuz J. Eur J Vasc Endovasc Surg 2007;34:397-404.
Objectives: Physicians are in a unique position to advise smokers to
quit by integrating the various aspects of nicotine dependence. This review
provides an overview of interventions for smokers presenting in a clinical
setting.
Results: Strategies used for smoking cessation counselling differ
according to patient’s readiness to quit. For smokers who do not intend
to quit smoking, physicians should inform and sensitise them about
tobacco use and cessation. For smokers who are dissonant, physicians
should use motivational strategies, such as discussing barriers to cessation
and their solutions. For smokers ready to quit, the physician should show
strong support, help set a quit date, prescribe pharmaceutical therapies
for nicotine dependence, such as nicotine replacement therapy (i.e., gum,
transdermal patch, nasal spray, mouth inhaler, lozenges, micro and
sublingual tablets) and/or bupropion (atypical antidepressant thought
to work by blocking neural reuptake of dopamine and/or nor epineph-
rine), with instructions for use, and suggest behavioural strategies to
prevent relapse. The efficacy of all of these pharmacotherapies is compa-
rable, roughly doubling cessation rates over control conditions. Vareni-
cline is a promising new effective drug recently approved by many health
authorities.
Conclusion: Physician counselling and pharmacotherapeutic interven-
tions for smoking cessation are among the most cost-effective clinical
interventions.
Effects of Percutaneous Transluminal Angioplasty and Endovascular
Brachytherapy on Vascular Remodeling of Human Femoropopliteal Ar-
tery: 2 Years Follow-up by Noninvasive Magnetic Resonance Imaging
Wyttenbach R., Corti R., Alerci M., Cozzi L., Di Valentino M., Segatto J.M.,
Badimon J.J., Fuster V., Gallino A. Eur J Vasc Endovasc Surg 2007;34:416-23.
Objectives:We aimed to assess in vivo the long-term effects of percu-
taneous transluminal angioplasty (PTA) and endovascular brachytherapy
(EVBT) on vessel wall by serial MRI.
Methods: Twenty patients with symptomatic stenosis of the femoro-
popliteal artery were randomly assigned to PTA (n10) or PTAEVBT
(n10, 14 Gy by -source). High-resolution MRI was performed prior, at
24-hours, 3-months, and 24-months after intervention. MRI data were
analyzed by an independent, blinded observer.
Results: The effects of both procedures on vessel wall at 24-hours and
3-months have been reported. Despite similar percent decrease in lumen
area between 3- and 24-months in both groups (8% for PTA and11% for
PTAEVBT), at 24-months lumen area gain compared to baseline was
30% in PTA versus 82% in PTAEVBT (p0.05). Total vessel area,
which was increased at 24-hours and 3-months, returned to pre-treatment
value in both groups.
Conclusions: We demonstrated non-invasively that restenosis and
inward remodeling after PTA are delayed by EVBT. At 24-months, patients
treated with brachytherapy have larger lumen than those treated with PTA
alone. The decrease in luminal and total vessel area between 3- and 24-
months after EVBT indicates that the restenotic and remodeling process is
not abolished but delayed with this therapy.
Cold-stored Venous Allografts in the Treatment of Critical Limb
Ischaemia
Matia I., Janoušek L., Marada T., Adamec M. Eur J Vasc Endovasc Surg
2007;34:424-31.
Objectives: To assess the outcome of cold-stored venous allografts in
critically ischemic limbs in patients with no ipsilateral autogenous greater
saphenous vein.
Design: A non-randomised, retrospective, single-center study.
Methods: From September 2000 to June 2006, 46 cold-stored venous
allografts obtained during multiorgan harvest were implanted into 44 criti-
cally ischaemic limbs of 43 patients. The indication for reconstructions was
rest pain (24%) or tissue lost (76%). Sixty-seven percent of procedures were
performed as secondary reconstructions, and 61% of veins were anastomosed
to tibial or pedal arteries. Thirty-seven percent of patients received pred-
nisone, and 46% tacrolimus as postoperative immunosuppressive therapy.
Mean patient follow-up period was 13.3 months (range 1 week to 60
months).
Results: The secondary patency rate for the cohort was 835.6% at 1
month, 648.2% at 6 months, 5710.0% at 12 months and 4610.7% at
24 months. Limb salvage rate was 963.1% at 1 month, 786.9% at 6
months, 718.1% at 12 months and 5011.8% at 24 months.
Conclusion: Cold-stored venous allografts are an alternative conduit
for limb salvage procedures when ipsilateral autogenous vein is unavailable.
Aneurysm Sac Pressure after EVAR: The Role of Endoleak
Hinnen J.W., Koning O.H.J., van Bockel J.H., Hamming J.F. Eur J Vasc
Endovasc Surg 2007;34:432-41
Objective:The relation between endoleak and aneurysm sac pressure is
not completely clear. This review evaluates the effect of endoleaks on
aneurysm sac pressure and summarizes the present knowledge regarding
aneurysm sac pressure after EVAR.
Methods: A systematic search of literature was carried out using
MEDLINE, EMBASE and Web of Science. Studies were included if aneu-
rysm sac pressure measurements as well as systemic pressure measurements
were performed during or after EVAR. Mean pressure indices (MPI), ratio
mean aneurysm sac pressure to mean systemic pressure), in the absence of
endoleaks and in the presence of different type of endoleaks were compared.
Results: Stent-graft deployment does not seem to result in immediate
reduction of aneurysm sac in the absence of an endoleak. Aneurysm sac
pressure is elevated in the presence of an endoleak. However, theMPIs differ
widely between studies both in the absence and presence of an endoleak.
Conclusion: MPI is not specific to the type of endoleak. This implies
that the same type of endoleak does not necessarily pose the same MPI and
by this the same hazard of aneurysm rupture, because the aneurysm sac
pressure is directly related to the aneurysm wall stress.
Long Term Outcome for Extra-anatomic Arch Reconstruction. An
Analysis of 143 Procedures
Byrne J., Darling R.C.III, Roddy S.P., Mehta M., Paty P.S.K., Kreienberg
P.B., Chang B.B., Ozsvath K.J., Sternbach Y., Shah D.M. Eur J Vasc
Endovasc Surg 2007;34:444-50.
Purpose: With the FDA approval of thoracic endografts, extra-ana-
tomic reconstruction of the aortic arch has allowed for more suitable
proximal landing zones and increased applicability of thoracic endovascular
procedures. We evaluated our short term and long term results of extra-
anatomic reconstruction of the carotid and subclavian vessels.
Methods: One hundred and forty three (143) procedures were per-
formed for extra-anatomic carotid and subclavian reconstruction. Of these
826
143 operations: 85 were carotid subclavian reconstructions, 22 were carotid
crossover bypasses, 30 were subclavian carotid reconstructions and 6 were
carotid subclavian transpositions. Sixty (42%) were male, 20 (14%) were
diabetic, and 63 (44%) were current smokers. Mean age was 63 (SD /
12.3). Indication for surgery was primarily for occlusive or embolic disease
(97%). In those patients undergoing bypass graft, prosthetic (ePTFE) was
used in 93%. Follow-up was performed at 3 and 6 month intervals by
ultrasound and pulse volume recordings where indicated. Life table analyses
were used to analyze patency.
Results: Of the 143 reconstructions operative mortality was 1 (0.7%).
Non-fatal complications included 3 (2.1%) for bleeding, 1 (0.7%) wound
infection, 2 (1.4%) TIA, 1 (0.7%) suffered a non-fatal stroke, 2 (1.4%) had
postoperative myocardial infarctions, and 6 (4.3%) late (30-day) occlu-
sions. Follow-up was 1 to 124 months (mean: 39 months). Primary patency
at 1 year was 98%, 3 years 96%, and 5 years was 92%.
Conclusion: Extra-anatomic arch reconstruction can be performed
safely and appears to be durable over long term follow-up. Its use with
endovascular grafting should provide a durable reconstruction for patients
who require aortic “debranching” prior endovascular thoracic aortic aneu-
rysm repair.
Spinal Cord Ischemia after Endovascular Repair of the Descending
Thoracic Aorta in a Sheep Model
Böckler D., Kotelis D., Kohlhof P., von Tengg-Kobligk H., Mansmann U.,
Zink W., Hörner C., Ortlepp I., Habel A., Kauczor H.-U., Graf B.,
Allenberg J.-R. Eur J Vasc Endovasc Surg 2007;34:461-69.
Objectives: Spinal cord ischemia remains a devastating complication
after thoracic aortic surgery. The aim of this study was to investigate the
pathophysiology of spinal cord ischemia after thoracic aortic endografting
and the role of intercostal artery blood supply for the spinal cord in a
standardized animal model.
Methods: Female merino sheep were randomized to either I, open
thoracotomywith cross-clamping of the descending aorta for 50 min (n7),
II, endograft implantation (TAG, WL Gore & Ass.), (n6) or III open
thoracotomywith clipping of all intercostal arteries (n5) . CT-angiography
was used to assess completion of surgical protocol and assess the fate of
intercostal arteries. Tarloy score was used for daily neurological examination
for up to 7 days post-operatively. Histological cross sections of the lumbar,
thoracic and cervical spinal cords were scored for ischemic damage after
stained with Hematoxylin-Eosin, Klüver-Barrrera and antibodies. Exact
Kruskall-Wallis-Test was used for statistical assessment (p0.05).
Results: Incidence of paraplegia was 100% in group I and 0% in group
II (p0.0004). When compared to the endovascular group, there was a
higher rate of histological changes associated with spinal cord ischemia in the
animals of the control group (p0.0096). Group III animals showed no
permanent neurological deficit and only 20% infarction rate (p0.0318
compared to group I).
Conclusions: In sheep, incidence of histological and clinical ischemic
injury of the spinal cord following endografting was very low. Complete
thoracic aortic stent-grafting was feasible without permanent neurologic
deficit. Following endovascular coverage or clipping of their origins, there is
retrograde filling of the intercostal arteries which remain patent.
Meta-analysis of Randomized Trials Comparing Carotid Endarterec-
tomy and Endovascular Treatment
Luebke T., Aleksic M., Brunkwall J. Eur J Vasc Endovasc Surg 2007;34:
470-79.
Objective and design: In order to evaluate the comparative efficacy
and safety of carotid angioplasty with or without stent placement (CAS)
versus carotid endarterectomy (CEA) we performed a meta-analysis of the
presently available randomized studies.
Materials and methods: A multiple electronic health database search
on all randomized trials describing CAS compared with CEA in patients with
symptomatic or asymptomatic carotid artery stenosis was performed.
Results: Seven trials totalling 2972 patients (1480 randomized to CEA
and 1492 randomized to CAS) were included in the meta-analysis. Results
significantly favoured CEA over CAS in terms of death or any stroke at 30
days after procedure; the risk of death, any stroke, or myocardial infarction at
30 days; ipsilateral ischaemic stroke at 30 days; any stroke at 30 days; death
or stroke at 6 months; and the risk of procedural failure.
There was a significantly reduced risk of cranial neuropathy at 30 days
after CAS. There was no significant difference between CAS and CEA
groups in the odds of death or disabling stroke at 30 days, death or stroke at
1 year after the procedure, and ipsilateral intracerebral bleeding at 30 days.
Conclusions:The results of this meta-analysis suggest that CEA can be
performed with more safety than CAS. As a result, CEA remains the “gold
standard” treatment for suitable de novo carotid stenosis and CAS should
only be performed within randomized trials of stenting versus surgery.
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